IHC analysis further revealed no significant associations between MAGED4 protein expression and clinicopathological parameters, including gender, age, tumor size, differentiation, TNM stage, lymph node metastasis, and the expression of ki-67, p53 and p16 (Table 1). This evidence concerns the gene MAGED4 and metastatic malignant neoplasm in the lymph nodes.